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Abstract 
Purpose: The present study investigated different doses of ultraviolet-A (UV-A) light on 
plasma nitric oxide metabolites and cardiorespiratory variables. 
Methods: Ten healthy male participants completed three experimental conditions, 7 days apart. 
Participants were exposed to no light (CON); 10 J•cm2 (15 min) of UV-A light (UVA10) and 
20 J•cm2 (30 min) of UV-A light (UVA20) in a randomized order. Plasma nitrite [NO2
-] and 
nitrate [NO3
-] concentrations, blood pressure (BP), and heart rate (HR) were recorded before, 
immediately after exposure and 30 min post-exposure. Whole-body oxygen utilization (V̇O2) 
and skin temperature were recorded continuously.   
Results: None of the measured parameters changed significantly during CON (all P>0.05). V̇O2 
was significantly reduced immediately after UVA10 (P=0.03) despite no change in plasma 
[NO2
-] (P>0.05). Immediately after exposure to UVA20, plasma [NO2
-] was higher (P=0.014) 
and V̇O2 tended to be lower compared to baseline (P=0.06). There were no differences in [NO2-
] or V̇O2 at the 30 min time-point in any condition. UV-A exposure did not alter systolic BP 
(SBP), diastolic BP or MAP (all P>0.05). UV-A light did not alter plasma [NO3
-] at any time 
point (all P>0.05).  
Conclusions: This study demonstrates that a UV-A dose of 20 J•cm2 is necessary to increase 
plasma [NO2
-] although a smaller dose is capable of reducing V̇O2 at rest. Exposure to UV-A 
did not significantly reduce BP in this cohort of healthy adults. These data suggest that 
exposure to sunlight has a meaningful acute impact on metabolic function.   
 
Key Words: Sunlight, Nitrate, Nitrite, Blood Pressure, metabolic rate 
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Abbreviations 
Analysis of variance: ANOVA 
Blood pressure (BP) 
Centimetres: cm 
Control: (CON) 
Degrees Celcius: ᴼC 
Degrees North: ᴼN  
Delta: Δ 
Diastolic BP: DBP 
Heart rate: HR 
Intravenous: I.V. 
Joules per centimetre squared: J•cm2 
Kilograms: kg 
Litre: L 
Mean arterial BP: MAP  
Microliter: µL 
Micromolar: µM 
Millimolar: mM 
Minutes: Min 
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Nanometers: nm 
Nanomolar: nM  
Nitrate: NO3
- 
Nitric Oxide: NO  
Nitric Oxide Synthases: NOS 
Nitrite: NO2
- 
Number: n  
Oxygen utilization: V̇O2  
Sodium hydroxide: NaOH  
Standard error of the mean: SEM 
Systolic BP: SBP 
Total nitrosated products: RXNO 
Ultraviolet- UV 
Ultraviolet-A: (UV-A) 
Ultraviolet Radiation: UVR 
Weighted volume: w/v 
Xanthinine oxioreductases: XOR 
Zinc Sulphate: ZnSO4 
10 J•cm2: (UVA10) 
20 J•cm2: (UVA20) 
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Introduction 
Nitric oxide (NO) is produced by NO synthases (NOS) from the oxidation of L-arginine and 
acts as a multifunctional signaling molecule that regulates a number of key biological processes 
including neuronal signaling, immune function, mitochondrial respiration, and vascular tone 
(Carr and Ferguson 1990; Moncada and Higgs 1991; Ignarro 2002). NO is rapidly oxidized 
within the human body to nitrite (NO2
-) and nitrate (NO3
-), with the latter accounting for the 
majority of NO-derived compounds within the body. Recent evidence suggests that NO3
- and 
NO2
- are important reservoirs of NO that act independently of NOS activity (Lundberg et al. 
2009, 2015). Although NO3
- is considered to be physiologically inert, it can be reduced to 
biologically active NO2
- by bacteria in the oral cavity (Duncan et al. 1995) and gut (Tiso and 
Schechter 2015) or reduced by xanthinine oxidoreductases (XOR) (Lundberg et al. 2009). NO2
- 
can initiate physiological effects or be reduced further to NO under hypoxic (Castello et al. 
2006) and acidic (Modin et al. 2001) conditions.  
Several studies have demonstrated that increasing plasma levels of NO3
- and NO2
- through 
dietary NO3
- ingestion and via sunlight exposure can reduce blood pressure (BP) (Larsen et al. 
2006; Webb et al. 2008; Opländer et al. 2009; Kapil  et al. 2010; Vanhatalo et al. 2010; Siervo 
et al. 2013; Wylie et al. 2013; Muggeridge et al. 2015; McIlvenna et al. 2017). Increasing the 
circulating concentration of NO metabolites has also been shown to elicit other cardiovascular 
and metabolic effects, including the reduction of resting oxygen utilization (V̇O2) (Larsen et 
al. 2014; Whitfield et al. 2016). Intriguingly, both dermis and epidermis contain NO2
- at 
concentrations substantially greater than those in blood (Paunel et al. 2005). Exposing the skin 
to light in the UV-A wavelength range (315-400nm) leads to photodecomposition of these NO 
derivatives and release of NO into the circulation with consequent biological effects (Paunel et 
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al. 2005; Mowbray et al. 2009; Suschek et al. 2010). UV-A induced NO production has been 
shown to be independent of NOS, temperature, and vitamin D status (Liu et al. 2014). Given 
that basal plasma [NO2
-] is suggested to be a marker of endothelial function (Kleinbongard et 
al. 2006), whereby low levels correlate with increased cardiovascular risk (Allen et al. 2009), 
UV-A induced NO production could conceivably modulate cardiovascular homeostasis.  
Despite the potential health significance of these observations, little is known about the 
minimal dose of UV-A exposure required to alter circulating NO levels. Whole body UV-A 
exposure of 20 J•cm2 (equivalent to ~30 min of Mediterranean summer sunlight) has been 
consistently shown to mobilize NO2
- from the skin into the plasma (Liu et al. 2014) and reduce 
systemic BP (Opländer et al. 2009; Liu et al. 2014; Muggeridge et al. 2015). To the best of our 
knowledge, this has been the only dose of UV-A used in human volunteer studies related to the 
mobilization of NO from skin. However, it has been shown in vitro that UV-A light of 9 J•cm2 
causes a dose-dependent increase in NO production in isolated keratinocytes without causing 
DNA damage (Holliman et al. 2017). This may be important as current public health messages 
favor sun avoidance due to the established carcinogenic effects of habitual UV exposure 
(Kennedy et al. 2003; Rigel 2008). Given that exposure to sunlight may impact positively on 
markers of cardiovascular health, further research is warranted to determine the minimum dose 
of UV-A exposure to elicit these effects.  
Therefore, the aim of the present study was to compare the effects of two different doses of 
UV-A light on plasma [NO2
-], [NO3
-], BP and resting V̇O2. We hypothesized that UV-A light 
would increase plasma NO derivatives and reduce MAP and resting V̇O2 in a dose-dependent 
manner.  
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2 Methods 
2.1. Participants 
Ten healthy males (age 28 ± 5 years, stature 180 ± 9 cm, body mass 80.8 ± 11.0 kg) volunteered 
to participate in the study following ethical approval by the School of Science and Sport Ethics 
Committee at the University of the West of Scotland. Participants self-determined their skin 
type via the Fitzpatrick Skin Questionnaire (Fitzpatrick 1988) as skin type 2 (n = 1) and skin 
type 3 (n = 9). Written informed consent was obtained from all participants prior to the 
commencement of the study. All participants were non-smokers, apparently healthy, were not 
regular users of anti-bacterial mouthwash, and reported no use of medication. Prior to each trial 
participants were instructed to avoid prolonged sunlight exposure and caffeine on the morning 
of each visit and to avoid NO3
- rich foods (such as beetroot and lettuce), high intensity exercise, 
and alcohol consumption within 48 h of each trial.  
 
2.2. Experimental design 
Each participant attended the laboratory on three separate occasions and was exposed to either 
no light (control, CON), 10 J•cm2 of UV-A light (UVA10), or 20 J•cm2 of UV-A light 
(UVA20), in a randomized counter-balanced order. Each condition was separated by 7 days 
and performed at the same time of day for each participant. Trials were performed in Scotland 
at 55.78ᴼN latitude between July and December. Each trial was conducted in the morning 
(before 11 am) after an overnight fast and following the consumption of ~500 ml of bottled 
water upon awakening. Dietary and exercise habits were self-recorded via a 48 h recall at the 
beginning of visit one and repeated on each visit thereafter. Compliance to these factors was 
determined at the beginning of each visit. 
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2.3. UV-A Exposure 
Whole body UV-A exposure was delivered using a commercially available UV-A light therapy 
system (Waldmann, UV302 L, Germany). UV-A light occurs naturally in the 315-400 nm 
wavelength band, and the present system emitted light at wavelengths between 315 and 351 
nm. In all conditions, participants lay supine on a medical plinth for the duration of the 
experiment and wore shorts and protective glasses. Participants were instructed to close their 
eyes for duration of the light exposures. During CON, the UV-A system remained off. The 
trials were conducted in a temperature-controlled laboratory (22 ± 1.3ᴼC). The dose of UV-A 
was automatically calculated based on exposure time and calibrated irradiance at a distance of 
21 cm from the abdominal skin. Exposure time was 15 min in UVA10 and 30 min in UVA20. 
Calibration of the UV-A light source was conducted as per the manufacturer’s instructions. 
 
2.4. Experimental procedures 
On arrival, stature and body mass were recorded following a bladder void. Upon lying supine 
for a period of 30 min prior to baseline measurements, an I.V. catheter was inserted into the 
antecubital vein of each participant for collection of venous blood samples. In the UVA10 
condition, participants lay supine for an additional 15 min prior to baseline measurements in 
order to time-match the duration of the experiment across all three conditions. Skin temperature 
was continuously monitored (Squirrel SQ2022, Cambridge, England) via thermistors placed at 
four anatomical sites (triceps, chest, quadriceps, and calf). Participants were fitted with a heart 
rate (HR) monitor (Polar Electro, Oy, Finland), which was continuously monitored by 
telemetry. Resting V̇O2 was measured via indirect calorimetry using breath-by-breath analysis 
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(Medgraphics, Milan, Italy). The volume measurement of the system was calibrated prior to 
each trial using a 3 L syringe as per the manufacturers’ instructions. Gas analyser calibration 
was performed with two gases of known concentrations (calibration gas: 5% carbon dioxide, 
12% oxygen and nitrogen balance and reference gas: 21% oxygen and nitrogen balance) (Air 
Liquide Healthcare, Belgium). Resting V̇O2 data were taken as an average for 20 min at 
baseline, during treatment, and for 30 min post-exposure. Upper and lower limits of agreement 
were calculated for resting V̇O2, and data points exceeding two standard deviations from the 
mean were excluded from analysis. Brachial BP was measured in triplicate with 1 min between 
measures at baseline, immediately after light exposure (0 min), and 30 min after exposure using 
a manual stethoscope and sphygmomanometer (Accoson, London, UK), with the pressure cuff 
placed at the upper part of the non-dominant arm positioned at the level of the right atrium. 
Mean values were used for analysis. Mean arterial BP (MAP) was calculated using the 
following equation:  MAP = [(2 x diastolic pressure + systolic) / 3]. Following each BP 
measure, 8 ml of venous blood was collected from the opposite arm at baseline, 0 min, and 30 
min post-exposure. Blood was collected in vacutainers containing EDTA and immediately 
centrifuged at 4000 rpm at 4oC for 10 min (Harrier 18/80, MSE, UK). Plasma was extracted 
and immediately stored at -80oC for later analysis of [NO3
-] and [NO2
-]. Intravenous lines were 
flushed with 2 ml of 0.9% saline solution immediately following each blood draw.  
 
2.5. Analysis of Plasma NO Metabolites 
Gas-phase chemiluminescence was used to determine plasma [NO3
-] and [NO2
-], as previously 
described (Pinder et al. 2008; Muggeridge et al. 2014; McIlvenna et al. 2017). Briefly, 
following the creation of a standard curve at several concentrations (0 to 1000nM for NO2
-) 
and (0 to 100µM for NO3
-), samples were thawed in a water bath at 37oC for 3 min. Plasma 
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samples were injected in duplicate into a customized enclosed purge vessel containing the 
respective reagent mixture. For the determination of NO2
-, a reagent containing 1% sodium 
iodide in 4 ml of glacial acetic acid kept at 50oC was used to reduce NO2
- to NO. 
 
Before the determination of NO3
-, plasma samples were deproteinized using zinc sulfate 
(ZnSO4) and sodium hydroxide (NaOH). Samples were made up in 1 ml aliquots (200uL 
plasma: 400µL ZnSO4 (10% w/v) and 400 µL NaOH solution (200 µL de-ionized water: 200 
µL 1M NaOH) and vortexed for 30 s. Samples were then centrifuged at 4000 rpm for 5 min 
and supernatants were used for NO3
- analysis. For the determination of NO3
-, a reagent 
containing 32 mg of vanadium trichloride (VCl3), 4 ml of 1M hydrochloric acid, and 500 µl of 
de-ionized water was used in a sealed purge vessel maintained at 95oC. NO was quantified 
using an NO analyzer (Sievers NOA 280; Analytix, UK). The area under the curve (AUC) was 
then used to determine concentrations by plotting the standard curve and dividing the AUC of 
each sample by the gradient of the slope. The co-efficient of variance (COV) for both plasma 
[NO2
-] and [NO3
-] was better than 5%.  
 
2.6 Data Analysis 
The distribution of the data were tested using the Shapiro-Wilk test. A two-way repeated-
measures ANOVA was used to examine the differences between ‘condition’, ‘time’ and the 
‘condition x time’ interaction for all variables. Post-hoc analysis of the significant main effects 
were conducted using paired t-tests and adjusted for multiple comparisons using the Bonferroni 
correction. Statistical significance was accepted at P  < 0.05. The inclusion of 95% CI for mean 
differences are presented with P values and effect sizes (Cohen’s D), when appropriate.  Effect 
sizes were interpreted as: small effect > 0.2; medium effect > 0.5; large effect > 0.8. Data were 
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analyzed using SPSS (Version 22.0) and Graph Pad Prism (Version 7.02). Data in the text are 
presented as mean ± standard deviation. Data in figures are presented as group delta (Δ) ± 
standard error of the mean (SEM) relative to pre-treatment baselines. 
 
3.1 Results 
3.1.1 NO Metabolites  
Plasma [NO2
-] changes are shown in Fig 1A. Plasma [NO2
-] was not different between the three 
conditions at baseline (CON 109 ± 54 nM, UVA10 108 ± 55 nM, UVA20 162 ± 75 nM, P = 
0.18). There was a significant main effect of ‘condition’ (P = 0.004), ‘time’ (P = 0.001) and 
‘condition x time’ interaction (P < 0.001) on plasma [NO2-]. Following UVA20, plasma [NO2-
] was increased from baseline at the 0 min time point (95% CI, 25.7 to 216.9; P = 0.014; d = 
1) but was not different at 30 min (P = 1.0; d = 0.2). Plasma [NO2
-] did not differ from baseline 
at the 0 min or the 30 min time points in both the CON and UVA10 trials (all P > 0.4, d < 0.3).   
 
Changes in plasma [NO3
-] are shown in Fig 1B. Plasma [NO3
-] was different between the three 
conditions at baseline (CON 45.6 ± 16.2 µM, UVA10 55.1 ± 21.9 µM, UVA20 39.5 ± 16.8 
µM, P = 0.04). Post hoc comparisons revealed baseline plasma [NO3
-] was higher in UVA10 
compared to UVA20 (95% CI, 0.4 to 31; P = 0.05; d = 1), but there was no difference between 
CON and UVA10 (P = 0.4) or CON and UVA20 (P = 0.9). There was a significant main effect 
for ‘condition’ (P = 0.013) on plasma [NO3-]. Overall, plasma [NO3-] was significantly higher 
in UVA10 when compared to UVA20 (95% CI, 2.5 to 25.6; P = 0.02; d = 1), but was not 
different to CON (P = 0.7). There was no significant main effect for ‘time’ (P = 0.7) or 
‘condition x time’ interaction (P = 0.109) for plasma [NO3-].  
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3.1.2 Blood Pressure, Heart Rate and Skin Temperature 
There was no significant ‘condition x time’ interaction for systolic BP (SBP) (P = 0.91; Table 
1), diastolic BP (DBP) (P = 0.19; Table 1) or MAP (P = 0.27; Figure 1C; Table 1). There was 
no difference in BP variables at baseline (P > 0.5; Table 1). Although no significant difference 
was observed in BP, effect sizes indicate that following UVA20, DBP reduced to a small extent 
immediately following (P = 0.3; d = 0.3) and 30 min (P = 0.15; d = 0.3) post-exposure. After 
UVA20, there was a small reduction in MAP immediately following exposure (P = 0.3; d = 
0.3) and a moderate decrease 30 min after exposure (P = 0.1; d = 0.5) when compared to 
baseline (Table 1). Skin temperature and HR data are shown in Table 1. There was no 
significant main effect of ‘condition x time’ for HR (P = 0.5). There was a trend towards a 
‘condition x time’ interaction for skin temperature (P = 0.06). Effect sizes show a small 
increase in skin temperature immediately following UVA20 (d = 0.4), but no difference 
between any other time points (d < 0.2).  
 
3.1.3 Resting V̇O2 
There was a significant ‘condition x time’ effect on resting V̇O2 (P = 0.047; Fig 1D). Resting 
V̇O2 was not different between the three conditions at baseline (CON 273 ± 37 ml/min-1, 
UVA10 267 ± 32 ml/min-1, UVA20 269 ± 37 ml/min-1; P= 0.8). Following UVA20, there was 
a trend for a reduction in resting V̇O2 at 0 min compared to the baseline (95% CI, -0.759 to 
36.1, P = 0.061; d = 0.4), but values were not different at 30 min (P = 1; d < 0.2). Following 
UVA10, resting V̇O2 was significantly reduced at 0 min (95% CI, 0.837 to 16.3; P = 0.03; d = 
0.3) but did not differ from baseline 30 min after exposure (P = 1; d < 0.2). In CON, resting 
V̇O2 did not change at 0 min or 30 min (both P = 1; d < 0.2). 
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4.1 Discussion  
Exposure to 20 J•cm2 of UV-A light, a dose equivalent to approximately 30 min of 
Mediterranean summer sunlight (Diffey 2002), has previously been shown to increase plasma 
[NO2
-] and lead to a sustained reduction in BP (Opländer et al. 2009; Liu et al. 2014). The 
present study explored the effects of different doses of UV-A exposure and the effects on 
circulating NO metabolites, BP, and resting V̇O2. The principal findings were that 20 J•cm2 of 
UV-A exposure resulted in a brief, but significant increase in plasma [NO2
-] whereas 10 J•cm2 
was insufficient to alter the concentration of this NO metabolite. In contrast to previous 
findings, exposure to UV-A light in either dose did not alter BP. However, we here demonstrate 
for the first time that exposure to UV-A light reduces resting V̇O2. While these data suggest 
that a minimum dose of 20 J•cm2 is necessary to augment plasma NO availability, further work 
is required to better understand the therapeutic effects of UV-A light on cardiovascular and 
metabolic health.  
 
4.1.1 Dose-Dependent Effects of UV-A Light on NO Metabolites 
The observed increase in plasma [NO2
-] following 20 J•cm2 but not 10 J•cm2 (~ 15 min of 
Mediterranean summer sunlight, or 40 min of British summer sunlight) of UV-A light supports 
our original hypothesis that the UV-induced release of NO metabolites from the skin is dose 
dependent. We demonstrate that 20 J•cm2 of UV-A light increased plasma [NO2
-] by 75% 
immediately following cessation of exposure, which is higher than the proportional increases 
of 45% (Opländer et al. 2009) and 40% (Liu et al. 2014) that have been previously reported. 
On the other hand, the absolute increase in plasma [NO2
-] was higher (~200 nM) in the study 
by Liu and colleagues (2014) was higher than in the present study (123 nM), Collectively, the 
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present study and other studies in the area (Opländer et al. 2009; Liu et al. 2014; Muggeridge 
et al. 2015) suggest that UV-A induced NO production may alter the overall circulating pool 
of NO. However, it is clear that there is profound inter-individual variability of NO2
- following 
UV-A challenge (Opländer et al. 2009). This may be explained by recent data from Holliman 
and colleagues (2017) who demonstrated diverging baseline levels of skin NO content in their 
skin donors and a variable magnitude of NO release from isolated keratinocytes in response to 
UV-A exposure. Both age and body composition are known to influence the storage and release 
of NO metabolites from the skin (Ma et al. 2015). These variables, along with skin type and 
habitual sunlight exposure may help explain the divergent response to UV-A between 
individuals and study cohorts.  The total storage of NO metabolites in the skin is likely to be 
important as it has recently been demonstrated in vitro that NO2
- is converted to NO upon UV-
A exposure (Holliman et al. 2017).  
 
In contrast to previous findings (Opländer et al. 2009; Liu et al. 2014), the observed increase 
in plasma [NO2
-] immediately following exposure with 20 J•cm2, was not sustained 30 min 
post-exposure. One possible explanation is that the source and delivery method for the UV-A 
light differed between all of these studies involving human volunteers. We speculate that the 
overall ‘dose’ or intensity of light may contribute to diverging NO2- release and overall NO 
kinetics. Previous studies have utilized the same dose of 20 J•cm2 of UV-A light (Opländer et 
al. 2009; Liu et al. 2014; Muggeridge et al. 2015), however over different time periods and 
intensities. In the present study, the intensity of light was the same in UVA10 and UVA20, 
where exposure time was manipulated to alter the overall dose. In vitro experiments highlight 
the relevance of the UV-A source showing that overall NO kinetics are altered depending on 
the distance from the UV-A light source (Dejam et al. 2003) and potentially the specific 
wavelength of the light. The middle to long UV-A wavelength range of 340-400 nm has been 
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shown to be the major contributor to overall NO production in isolated keratinocytes in 
response to UV-A challenge (Holliman et al. 2017). In the present study, our UV-A light source 
emitted its maximum intensity at 351 nm.  
 
 
 
In contrast with previous research, plasma [NO3
-] was not altered by UV-A exposure. Although 
we found no change in this variable, we speculate that the study was underpowered to see 
pronounced effects of UV-A exposure on plasma [NO3
-], particularly in the first 30 mins. Liu 
and colleagues (2014) have previously demonstrated that 20 J•cm2 of UV-A light significantly 
reduced [NO3
-]. The authors suggested that UV-A exposure may enhance the enzymatic 
conversion of NO3
- to NO2
- and that there may be some direct photolysis of NO3
- that yields 
NO. Future research is warranted to elucidate the role of UV-A induced alterations in plasma 
NO3
-. Our data supports the notion that NO2
- is more rapidly altered following UV-A challenge.  
 
4.1.2 Blood Pressure is not altered by UV-A light 
Our study demonstrated that UV-A light did not significantly alter BP. This finding contrasted 
our study hypothesis and previous research which has demonstrated that 20 J•cm2 effectively 
reduces BP in a healthy cohort (Opländer et al. 2009; Liu et al. 2014). Nevertheless, there was 
a moderate reduction in MAP (d = 0.5) 30 min after exposure in the UV20 condition with a 
concomitant moderate reduction in heart rate (d = 0.5). It should be highlighted that the small 
sample of participants in this study were all young, healthy, and normotensive males. The most 
likely explanation for the absence of a significant reduction in BP was that the elevation in 
plasma [NO2
-] was not sustained long enough to elicit a pronounced biological effect.  
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The experimental procedures may also have limited the extent to which UV-A light may have 
reduced BP. Specifically, the measurement of BP following the treatments in each condition 
was preceded by a 1 h period of lying supine. The consequence is that this sustained period of 
lying supine likely induced postural venodilation (Gemignani et al. 2008) and lowered BP prior 
to the experimental intervention. Indeed, DBP was 70 ± 7 mmHg and MAP was 85 ± 6 mmHg 
at baseline across all three conditions. This may have limited any further biologically 
significant reductions in BP following UV-A exposure. Recently, we have shown that posture 
and the period of time of lying supine can alter both BP and plasma [NO2
-] (Liddle et al. 2017), 
which emphasizes that posture should be carefully considered when conducting future research 
in this area. Although it has been suggested that even small reductions in BP are protective 
against cardiovascular incidence (Lawes et al. 2004), the clinical and biological significance of 
the small reductions in this study are unclear.  
 
4.1.3 UV-A Light Reduces V̇O2 
A notable finding in this study is that V̇O2 fell during both light exposures. To our knowledge, 
this study is the first to explore the effects of UV-A light on resting metabolism in humans. A 
significant reduction in resting V̇O2 was observed despite no elevation in plasma [NO2-] during 
UVA10, whereas a trend for a reduction was found in the presence of a significant elevation in 
plasma [NO2
-] in UVA20. While the mechanisms accounting for the reduction in V̇O2 could 
not be ascertained in the present study, we speculate that the complexity of NO conversion and 
appearance from NO2
- or other nitrogen oxides following UV-A challenge may have accounted 
for this finding. We hypothesized that resting V̇O2 would be reduced in the presence of elevated 
NO2
- as others have shown that NO2
- inhibited respiration by ~60% when applied to primary 
skeletal myotubes, in vitro (Larsen et al. 2011). Others have demonstrated that increasing 
plasma [NO2
-] and NO bioavailability via dietary NO3
- supplementation reduces V̇O2 at rest 
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(Larsen et al. 2014; Whitfield et al. 2016). Larsen and colleagues (2014) speculated that the 
reduction in resting metabolic rate was most likely due to an NO-mediated inhibition of 
cytochrome c oxidase (Carr and Ferguson 1990) and found that changes in this parameter 
following dietary NO3
- were independent of insulin sensitivity and thyroid hormones. 
However, Whitfield and Colleagues (2016) observed a similar reduction in whole body V̇O2 at 
rest, in the absence of change in skeletal muscle mitochondrial respiration. It is conceivable 
that the changes in resting V̇O2 observed in the present study following UV-A may have 
occurred via other NO-related mechanisms involving species distinct from those of the 
canonical NO3
-- NO2
- - NO pathway. It must also be considered that the absence of an elevation 
in plasma NO2
- following UVA10 and presence in UVA20 may be indicative of an NO-
independent mechanism. 
 
The reduction in V̇O2 following UV-A exposure appears to be transient as values returned to 
baseline 30 min after exposure in both light exposure conditions. The biological consequences 
of a sustained reduction in resting V̇O2 following UV-A exposure are unclear but must be 
considered as contraindicative for energy balance. This is of relevance given the composition 
of UV-A in overall sunlight exposure is approximately 90% (Diffey 2002). Furthermore, UV 
exposure has been proposed as a potential intervention for obesity and cardiometabolic 
dysfunction (Geldenhuys et al. 2014; Fleury et al. 2016), potentially via vitamin D or NO 
mediated effects (Gorman et al. 2017). Although the precise mechanism of the UV-A induced 
reduction in V̇O2 are unknown, the present study further highlights that sunlight exposure may 
have a potentially confounding impact on key markers of cardiometabolic health, which should 
be considered in epidemiological research.  
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4.1.4 Limitations  
The present study is not without limitations. Firstly, the study lacked ecological validity in the 
sense that acute exposure to artificial UV-A light in the laboratory tells us little about the 
relevance of environmental sunlight exposure for habitual vascular homeostasis. Secondly, 
while our data suggests there is a minimum dose of UV-A light exposure that is required to 
elicit meaningful increases in NO bioavailability, the existence of a dose-response relationship 
cannot be ascertained without more extensive investigations. Although we observed an 
increase in plasma [NO2
-] following 30 min of simulated sunlight exposure, we did not assess 
its release from skin stores and are therefore unable to provide a comprehensive assessment of 
the kinetic changes in NO derivatives and release from the skin. Such data are necessary to 
truly understand the role of the skin in the regulation of NO bioavailability and to establish 
whether UV-A exposure may be cardioprotective.  
 
5.1 Conclusions 
The present study is the first to determine that at least 20 J•cm2 of UV-A exposure (~30 min of 
Mediterranean summer sunshine) is required to significantly increase plasma [NO2
-] in healthy 
human participants. Surprisingly, elevations in plasma NO availability were not met with a 
significant reduction in BP, which has been consistently observed in previous studies. These 
contrasting data may relate to experimental differences in UV-A exposure protocols or inter-
individual variability in responses between participants. Although BP was not reduced in this 
study, UV-A exposure in doses of either 10 or 20 J•cm2 reduced resting V̇O2. These data provide 
further evidence to suggest that environmental exposures of sunlight may have a meaningful 
impact on cardiovascular and metabolic function.  
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Figure 1: A Plasma [NO2-]; B Plasma [NO3-]; C Mean arterial pressure; and D resting oxygen utilization 
(V̇O2), D following no exposure (CON•), 10 J•cm2 (UVA10 ▪), and 20 J•cm2 (UVA20▲) of UV-A light 
(group delta (Δ) mean ± SEM). Shaded area signifies the period of UV-A light exposure in UVA10 and 
UVA20. * Denotes significant increase in plasma NO2- compared to baseline.  
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